Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 386

1.

Exploitation of Natural Killer (NK) cells for the treatment of acute leukemia.

Handgretinger R, Lang P, André MC.

Blood. 2016 May 20. pii: blood-2015-12-629055. [Epub ahead of print]

PMID:
27207791
2.

mRNA-Mediated Gene Supplementation of Toll-Like Receptors as Treatment Strategy for Asthma In Vivo.

Zeyer F, Mothes B, Will C, Carevic M, Rottenberger J, Nürnberg B, Hartl D, Handgretinger R, Beer-Hammer S, Kormann MS.

PLoS One. 2016 Apr 21;11(4):e0154001. doi: 10.1371/journal.pone.0154001. eCollection 2016.

3.

Collagen VII Half-Life at the Dermal-Epidermal Junction Zone: Implications for Mechanisms and Therapy of Genodermatoses.

Kühl T, Mezger M, Hausser I, Guey LT, Handgretinger R, Bruckner-Tuderman L, Nyström A.

J Invest Dermatol. 2016 Jun;136(6):1116-23. doi: 10.1016/j.jid.2016.02.002. Epub 2016 Feb 18.

PMID:
26899947
4.

Proceedings from the Second Haploidentical Stem Cell Transplantation Symposium-Haplo2014, San Francisco, California, December 4, 2014.

Al Malki MM, Horowitz M, Handgretinger R, Leung W, Roy DC, Huang XJ, Fuchs E, Locatelli F, Blaise D, Mineishi S, Martelli M, Miller J, June C, Ai HS, Luznik L, Mavilio D, Lugli E, van den Brink MR, Champlin RE, Ciurea SO.

Biol Blood Marrow Transplant. 2016 Apr;22(4):594-604. doi: 10.1016/j.bbmt.2016.01.001. Epub 2016 Jan 13.

PMID:
26806585
5.

Isolation and Ex Vivo Culture of Vδ1+CD4+γδ T Cells, an Extrathymic αβT-cell Progenitor.

Welker C, Handgretinger R, Schilbach K.

J Vis Exp. 2015 Dec 7;(106):e53482. doi: 10.3791/53482.

PMID:
26709831
6.

Targeting hedgehog signalling by arsenic trioxide reduces cell growth and induces apoptosis in rhabdomyosarcoma.

Boehme KA, Zaborski JJ, Riester R, Schweiss SK, Hopp U, Traub F, Kluba T, Handgretinger R, Schleicher SB.

Int J Oncol. 2016 Feb;48(2):801-12. doi: 10.3892/ijo.2015.3293. Epub 2015 Dec 15.

PMID:
26676886
7.

Ferritin as an early marker of graft rejection after allogeneic hematopoietic stem cell transplantation in pediatric patients.

Döring M, Cabanillas Stanchi KM, Feucht J, Queudeville M, Teltschik HM, Lang P, Feuchtinger T, Handgretinger R, Müller I.

Ann Hematol. 2016 Jan;95(2):311-23. doi: 10.1007/s00277-015-2560-3. Epub 2015 Nov 27.

PMID:
26611853
8.

Modified mRNA as a new therapeutic option for pediatric respiratory diseases and hemoglobinopathies.

Antony JS, Dewerth A, Haque A, Handgretinger R, Kormann MS.

Mol Cell Pediatr. 2015 Dec;2(1):11. doi: 10.1186/s40348-015-0022-6. Epub 2015 Nov 20.

9.

Hoechst 33342 Staining Identifies the Progenitor Side Population in NOD.Cg-PrkdcscidIL2rgtmWjl/Sz Mice Harboring Pediatric Leukemias.

Andre MC, Witte KE, Hoerrmann RA, Schmitt A, Handgretinger R, Ebinger M.

In Vivo. 2015 Nov-Dec;29(6):661-9.

PMID:
26546522
10.

Posaconazole plasma concentration in pediatric patients receiving antifungal prophylaxis after allogeneic hematopoietic stem cell transplantation.

Heinz WJ, Cabanillas Stanchi KM, Klinker H, Blume O, Feucht J, Hartmann U, Feuchtinger T, Lang P, Handgretinger R, Döring M.

Med Mycol. 2016 Feb;54(2):128-37. doi: 10.1093/mmy/myv087. Epub 2015 Oct 18.

PMID:
26483433
11.

Enriched Bone Marrow Derived Disseminated Neuroblastoma Cells Can Be a Reliable Source for Gene Expression Studies-A Validation Study.

Rifatbegovic F, Abbasi MR, Taschner-Mandl S, Kauer M, Weinhäusel A, Handgretinger R, Ambros PF.

PLoS One. 2015 Sep 11;10(9):e0137995. doi: 10.1371/journal.pone.0137995. eCollection 2015.

12.

Cytokine serum levels during post-transplant adverse events in 61 pediatric patients after hematopoietic stem cell transplantation.

Döring M, Cabanillas Stanchi KM, Mezger M, Erbacher A, Feucht J, Pfeiffer M, Lang P, Handgretinger R, Müller I.

BMC Cancer. 2015 Aug 28;15:607. doi: 10.1186/s12885-015-1616-z.

13.

Pediatric T-cell lymphoblastic leukemia evolves into relapse by clonal selection, acquisition of mutations and promoter hypomethylation.

Kunz JB, Rausch T, Bandapalli OR, Eilers J, Pechanska P, Schuessele S, Assenov Y, Stütz AM, Kirschner-Schwabe R, Hof J, Eckert C, von Stackelberg A, Schrappe M, Stanulla M, Koehler R, Avigad S, Elitzur S, Handgretinger R, Benes V, Weischenfeldt J, Korbel JO, Muckenthaler MU, Kulozik AE.

Haematologica. 2015 Nov;100(11):1442-50. doi: 10.3324/haematol.2015.129692. Epub 2015 Aug 20.

14.

Preemptive administration of human αβ T cell receptor-targeting monoclonal antibody GZ-αβTCR potently abrogates aggressive graft-versus-host disease in vivo.

Blank G, Welker C, Sipos B, Sonntag K, Müller F, Eckert F, Seitz C, Nadalin S, LaCorcia G, Königsrainer A, Snell D, Handgretinger R, Schilbach K.

Ann Hematol. 2015 Nov;94(11):1907-19. doi: 10.1007/s00277-015-2471-3. Epub 2015 Aug 13.

PMID:
26264693
15.

NKG2D Signaling Leads to NK Cell Mediated Lysis of Childhood AML.

Schlegel P, Ditthard K, Lang P, Mezger M, Michaelis S, Handgretinger R, Pfeiffer M.

J Immunol Res. 2015;2015:473175. doi: 10.1155/2015/473175. Epub 2015 Jul 8.

16.

Nifurtimox reduces N-Myc expression and aerobic glycolysis in neuroblastoma.

Cabanillas Stanchi KM, Bruchelt G, Handgretinger R, Holzer U.

Cancer Biol Ther. 2015;16(9):1353-63. doi: 10.1080/15384047.2015.1070987. Epub 2015 Jul 15.

PMID:
26177922
17.

Rapid generation of NY-ESO-1-specific CD4+ THELPER1 cells for adoptive T-cell therapy.

Kayser S, Boβ C, Feucht J, Witte KE, Scheu A, Bülow HJ, Joachim S, Stevanović S, Schumm M, Rittig SM, Lang P, Röcken M, Handgretinger R, Feuchtinger T.

Oncoimmunology. 2015 May 21;4(5):e1002723. eCollection 2015 May.

18.

Chronic graft-versus-host-disease in CD34(+)-humanized NSG mice is associated with human susceptibility HLA haplotypes for autoimmune disease.

Sonntag K, Eckert F, Welker C, Müller H, Müller F, Zips D, Sipos B, Klein R, Blank G, Feuchtinger T, Schumm M, Handgretinger R, Schilbach K.

J Autoimmun. 2015 Aug;62:55-66. doi: 10.1016/j.jaut.2015.06.006. Epub 2015 Jul 3.

PMID:
26143958
19.

Cancer-targeted IL-12 controls human rhabdomyosarcoma by senescence induction and myogenic differentiation.

Schilbach K, Alkhaled M, Welker C, Eckert F, Blank G, Ziegler H, Sterk M, Müller F, Sonntag K, Wieder T, Braumüller H, Schmitt J, Eyrich M, Schleicher S, Seitz C, Erbacher A, Pichler BJ, Müller H, Tighe R, Lim A, Gillies SD, Strittmatter W, Röcken M, Handgretinger R.

Oncoimmunology. 2015 Mar 19;4(7):e1014760. eCollection 2015 Jul.

20.

Donor choice in haploidentical stem cell transplantation: fetal microchimerism is associated with better outcome in pediatric leukemia patients.

Kruchen A, Stahl T, Gieseke F, Binder TM, Özcan Z, Meisel R, Kreyenberg H, Bader P, Gruhn B, Greil J, Pfeiffer M, Döring M, Handgretinger R, Fehse B, Müller I.

Bone Marrow Transplant. 2015 Oct;50(10):1367-70. doi: 10.1038/bmt.2015.136. Epub 2015 Jun 22. No abstract available.

PMID:
26098953
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk